ArticleZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences2026
[Effect of glycemic variability on the efficacy of artificial pancreas systems: A real-world study].
Article in Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectivesThe artificial pancreas system (APS) has become an important technological approach for the treatment of type 1 diabetes mellitus (T1DM). However, whether patients with different baseline levels of coefficient of variation (
methodsThis retrospective real-world study enrolled patients with T1DM who initiated AndroidAPS (AAPS) through online diabetes communities between January 2019 and April 2024. All participants continuously used AAPS for at least 3 months, and each open-loop interruption lasted no longer than 7 d. Original continuous glucose monitoring (CGM) data were obtained from the Nightscout cloud platform. CGM data from the first 7 d after AAPS initiation were used as baseline values, and the study period was defined as the first 3 months after AAPS initiation. According to internationally recommended cutoff values, patients were categorized into a glycemic stability group (
resultsA total of 132 patients with T1DM were included, among whom 88 (66.67%) were assigned to the glycemic stability group and 44 (33.33%) to the glycemic instability group. No statistically significant differences were observed between the 2 groups in sex, age, body mass index (BMI), disease duration, glycated hemoglobin A1c (HbA1c) at diagnosis, or chronic complications (all
conclusionsBaseline
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.